Omega-3 & LDL Cholesterol: What You Need to Know
- As interest in omega-3 fatty acids grows, pharmacists need to understand their effects on patients.
- Qian explained that low doses of omega-3s, around 1 gram daily, usually don't change LDL cholesterol levels.
- According to Qian, the LDL increase might be due to DHA's triglyceride-lowering effect.
Understand the impact of omega-3 fatty acids on your LDL cholesterol. Recent research presented at the National Lipid Association Scientific Sessions reveals that while low doses (1 gram daily) of omega-3s typically don’t affect LDL cholesterol, higher doses of EPA/DHA mixtures (4 grams daily) may lead to a slight increase. Purified EPA formulations, however, may not raise LDL levels. Discover which patient groups—those with diabetes, CKD, or high triglycerides—benefit most from omega-3 fatty acid therapy. Be aware of potential side effects, like GI issues and a small risk of atrial fibrillation, as highlighted by Dr. Frank Qian. This facts, brought to you by News Directory 3, empowers pharmacists and patients alike to make informed decisions about omega-3 supplementation. Discover what’s next in the evolving science of lipids.
Omega-3 Fatty Acids: Understanding the Impact on LDL Cholesterol and Patient Safety
Updated June 01, 2025
As interest in omega-3 fatty acids grows, pharmacists need to understand their effects on patients. At the 2025 National Lipid Association Scientific Sessions, Dr. Frank Qian of Boston Medical Center discussed the latest research. He addressed LDL cholesterol changes, who benefits most, and safety issues like atrial fibrillation.
Qian explained that low doses of omega-3s, around 1 gram daily, usually don’t change LDL cholesterol levels. Though, higher doses, especially EPA and DHA mixtures (4 grams daily), might cause a slight increase, about 5% to 10%.Purified EPA, like that used in the REDUCE-IT trial, doesn’t seem to increase LDL cholesterol.
According to Qian, the LDL increase might be due to DHA’s triglyceride-lowering effect. This could trigger a compensatory rise in LDL cholesterol.
Certain patients benefit more from omega-3 fatty acid therapy. The REDUCE-IT and JELIS trials showed that individuals with diabetes, chronic kidney disease (CKD), or elevated triglycerides see the most significant advantages. These conditions increase atherosclerotic risk, making these patients higher-risk.
Qian noted common side effects like gastrointestinal issues, including dyspepsia, fishy aftertaste, or diarrhea. Taking omega-3s with meals can reduce these effects and improve absorption. He also cautioned about atrial fibrillation, a small but consistent risk with high-dose omega-3s, around 1% to 2%. However, trials like REDUCE-IT showed no increased stroke risk despite the higher atrial fibrillation incidence.
Bleeding risk is another consideration. While minor bleeding events where slightly elevated in REDUCE-IT, there was no significant increase in major bleeding complications.
“for lower doses… there is generally no significant change in LDL-C levels.However, at higher doses… there is typically a small increase in LDL-C, usually around 5% to 10%,” Qian said.
What’s next
Pharmacists should stay informed about ongoing research to better counsel patients on the appropriate use and potential risks and benefits of omega-3 fatty acid supplementation.